Dentists in Santa Fe Springs, CA Accepting Medicare
5 Dentists found. Showing 1 - 5
 Chawhsiung Chow Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 12155 Mora Dr, Santa Fe Springs, CA 90670 Phone: 562-903-7741 |
Dr. Michael S Lim, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 12155 Mora Dr Ste 15, Santa Fe Springs, CA 90670 Phone: 562-903-7741 |
Francisco J. Marquez, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 10009 Orr And Day Rd, Santa Fe Springs, CA 90670 Phone: 562-484-0808 Fax: 562-484-0804 |
 Annie Chow Dentist Medicare: Not Enrolled in Medicare Practice Location: 12155 Mora Drive, Santa Fe Springs, CA 90670 Phone: 562-903-7741 |
Dr. Scott H Ha, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 11452 Telegraph Rd, Santa Fe Springs, CA 90670 Phone: 562-929-1800 Fax: 562-929-2980 |
News Archive
SHEA urges CDC to remove the use of N95 respirators from its recommendations for routine care
Today's announcement by the Centers for Disease Control and Prevention (CDC) that it is modifying its guidance regarding measures that should be taken by healthcare workers who are in contact with either confirmed or suspected cases of H1N1 was met with concern by the scientific community that had submitted its recommendations to CDC.
Researchers develop protein-based biosensor for multiplex imaging of neurotransmitter
In 2018, Lin Tian and her team at UC Davis Health developed dLight1, a single fluorescent protein-based biosensor. This family of highly specific sensors detects dopamine, a hormone released by neurons to send signals to other nerve cells.
Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103
Antisense Therapeutics Limited is pleased to announce that the Company has now completed repeat-dosing toxicology studies for ATL1103 in two species - mouse and non-human primate. Draft study reports from the study contractors in the United States have been received, and the toxicology outcomes from these studies support ANP's plans for the continued development of ATL1103.
FDA announces consent decree of permanent injunction against Deltex
The U.S. Food and Drug Administration today announced that the U.S. District Court for the Southern District of Texas entered a consent decree of permanent injunction against Deltex Pharmaceuticals Inc., of Rosenberg, Texas, its president, Kabir Ahmed, and vice president, Mohidur R. Khan.
Rigel Pharmaceuticals, AstraZeneca license agreement: Waiting period under Antitrust Improvements Act expires
Rigel Pharmaceuticals, Inc. today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 relating to the license agreement between Rigel and AstraZeneca, the effectiveness of which was contingent on the expiration of the waiting period.
› Verified 5 days ago
Counselors
Clinical Social Workers
Pharmacists
Psychologists
Occupational Therapists
Dentists